Cargando…
Clinical Development of New Antibody–Drug Conjugates in Breast Cancer: To Infinity and Beyond
Metastatic breast cancer remains an incurable disease, and new therapies are needed. One major limitation of chemotherapy is the toxicity associated with higher dose exposure. Antibody–drug conjugates (ADCs) are a complex and evolving class of agents specifically designed with the objective of deliv...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933915/ https://www.ncbi.nlm.nih.gov/pubmed/33666903 http://dx.doi.org/10.1007/s40259-021-00472-z |